Bausch Health Companies To Present Latest Products

Pharmaceutical Investing

Bausch + Lomb, a subsidiary of Bausch Health Companies, announced the presentation of 26 new scientific analyses and three posters at the upcoming American Society of Cataract and Refractive Surgery Annual Meeting.

Bausch + Lomb, a subsidiary of Bausch Health Companies (NYSE:BHC,TSX:BHC), announced the presentation of 26 new scientific analyses and three posters at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting.

As quoted in the press release:

“These new scientific presentations reflect the positive experiences that ophthalmic surgeons are having with Bausch + Lomb products, including the Stellaris Elite™ vision enhancement system and enVista intraocular lenses,” said Joe Gordon, U.S. president, Bausch + Lomb. “We are pleased and proud to see so many of our customers and their patients benefiting from our technologies, and grateful for their willingness to share their data, experiences and insights with others attending the ASCRS meeting.”
The company will also hold a number of educational events and its first in-booth #ExperienceExchange where customers will have the opportunity to join internationally recognized surgeons in a one-on-one setting to discuss best practices, learn from the experiences of their peers and get more clinical insight into Bausch + Lomb surgical technologies. These include the Stellaris Elite vision enhancement system for cataract and retina surgery, the VICTUS femtosecond laser for advanced cataract and corneal applications, and its broad selection of intraocular lenses (IOLs) and delivery systems, including the enVista MX60E with StableFlex technology and the enVista toric MX60T.

Click here to read the full press release.

Pharmaceutical Investing